The Life Sciences industry is facing significant challenges related to escalating drug development costs, regulatory uncertainty and patient expectations regarding quality in medical treatment. In an effort to meet rising expectations, organizations are looking to leverage innovation within digital technology. The effectiveness of these technologies is underpinned by the quality of their data. Seeing that 80% of an organizations data is currently dormant or dark (unstructured), it is critical first step to understand how a Life Sciences company can enrich their data to surface the information needed to drive successful business outcomes.
|
